XTL Biopharmaceuticals Ltd ADR (US: XTLB) — Healthcare · Share Price, Chart & Market Data
About: XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.43 (-0.61%)
XTLBXTL Biopharmaceuticals Ltd ADR
Loading watchlist status…
Trade XTLB now
XTL Biopharmaceuticals Ltd ADR share price
XTLB price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:14 am GMT+0
XTLB price performance
-1.619%
5D
-3.187%
1M
1.25%
YTD
-88.75%
1Y
XTLB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:14 am GMT+0
XTLB details
XTLB Market Signals